For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 24-30, 2026
FDA and innovation FDA and CMS move on personalized gene therapies. The FDA released draft guidance that lets developers of…
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Search Posts
Study
This Liberal Congress Went to Market: a Bipartisan Policy Agenda for the 110th Congress
DO…
Blog
Drug Industry Gone to the Dogs
My dog is fat. Obese, even, if the FDA is to be believed. The arrival of my new-born son two years ago has meant fewer…
News Release
A Free Market Agenda for the 110th Congress
Contact: Richard Morrison, 202.331.2273 Washington, D.C., January 10, 2007—Today the Competitive Enterprise Institute releases its policy recommendations for the new leadership…
Op-Eds
The Democrats’ Favorite Target
Politicians always talk about promoting the public interest, but in practice that usually means helping your friends and hurting your enemies. The Democrats taking…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CONGRESS Democratic leaders in Congress begin work on their first 100 hour agenda.
News Release
Assessing the Agenda for Congress’ First 100 Hours
Contact: Richard Morrison, 202.331.2273 <?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Assessing…